isoxazoles has been researched along with Canine Diseases in 137 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (0.73) | 18.2507 |
2000's | 1 (0.73) | 29.6817 |
2010's | 115 (83.94) | 24.3611 |
2020's | 20 (14.60) | 2.80 |
Authors | Studies |
---|---|
Akki, FE; Beugnet, F; Lebon, W; Madder, M; Meyer, L | 1 |
Barbosa-Silva, AN; Brito, CRDN; da Câmara, ACJ; de Araújo-Neto, VT; de Medeiros, HR; de Sena, ER; Dos Santos, WV; Fagundes-Neto, JC; Ferreira, HRP; Galvão, LMDC; Gama, RA; Gomez, LCP; Guedes, PMM; Lima, RKDR; Nascimento, MSL; Queiroga, TBD | 1 |
Beugnet, F; Iatta, R; Lebon, W; Lia, RP; Otranto, D; Panarese, R | 1 |
Acevedo-Arcique, CM; Baak-Baak, CM; Chan-Pérez, JI; Gutiérrez-Blanco, E; Jiménez-Coello, M; Ortega-Pacheco, A; Poot-Ramos, A | 1 |
Alvedro, A; Cardinal, MV; Enriquez, GF; Gaspe, MS; Gürtler, RE; Laiño, MA; Macchiaverna, NP | 1 |
Bongiorno, G; Chiummo, R; Doherty, P; Evans, A; Gradoni, L; Lekouch, N; Meyer, L | 1 |
Alberto Carlos, RS; Brandão Guedes, PE; Chiummo, RM; da Paixão Sevá, A; de Almeida Borges, F; de Jesus, AV; de Oliveira, JTS; Dos Santos Freire, Z; Dos Santos, KC; Harvey, TV; Heckeroth, AR; Krücken, J; von Samson-Himmelstjerna, G; Zschiesche, E | 1 |
Drag, M; Mitchell, E; Tielemans, E | 1 |
Beugnet, F; Deak, G; Mihalca, AD; Panait, LC; Rabei, Ș | 1 |
Berny, P; Beugnet, F; Brianti, E; España, B; Marino, M; Mendoza-Roldan, JA; Napoli, E; Otranto, D; Perles, L; Spadola, F | 1 |
Gaens, D; Geyer, J; Hamann, M; Rummel, C; Schmidt, M | 1 |
Aouiche, N; Beugnet, F; Lebon, W; Lekouch, N; Meyer, L; Perier, N | 1 |
Bianchi, R; Bongiorno, G; Chiummo, R; Evans, A; Gradoni, L; Khoury, C; Lekouch, N; Meyer, L; Thomas, E | 1 |
Beugnet, F; Meesaimongkon, P; Srifawattana, N; Tangtrongsup, S; Thitaram, N; Tinkruejeen, G; Tiwananthagorn, S | 1 |
Inskeep, T; Kryda, K; Mahabir, SP; Rugg, J | 1 |
Bullock, R; Carney, E; Dodds, WJ; Fritsche, HA; Jeffrey, J; Kimball, JP; Morgan, J; Palmieri, V | 1 |
Chiummo, R; Karas-Tecza, J; Petersen, I; Rapti, D; Roepke, R; Thomas, E; Zschiesche, E | 1 |
Allen, K; Barrett, A; Gruntmeir, J; Guerino, F; Herrin, B; Little, S; Petersen, M; Starkey, L; Sun, F | 1 |
Armstrong, R; Lavan, R; Lipworth, K; Newbury, H; Normile, D | 1 |
da Câmara, ACJ; de Araújo Neto, VT; de Assis, ABL; Dos Reis, RK; Dos Santos, WV; Fagundes Neto, JC; Ferreira, HRP; Gama, RA; Guedes, PMM; Nascimento, MSL; Queiroga, TBD | 1 |
Akita, T; Hoshino, T; Machida, Y; Nagata, M; Okamura, T; Sugeno, A | 1 |
Beugnet, F; Cutolo, AA; Menz, I; Perier, N; Silva, FO; Thyssen, P | 1 |
Beugnet, F; Iatta, R; Mendoza-Roldan, JA; Otranto, D; Panarese, R; Zatelli, A | 1 |
Armstrong, R | 2 |
Dumont, P; Larsen, D; Lebon, W; Rehbein, S; Taweethavonsawat, P; Tielemans, E | 1 |
Mahabir, SP; Myers, MR; Six, RH; Young, DR | 3 |
Altet, L; Ferrer, L; Lam, ATH; Zewe, CM | 1 |
Lappin, MR; Legare, M; Sato, M; Veir, JK | 1 |
Armstrong, R; Heckeroth, AR; Kohler-Aanesen, H; Péré, K; Saari, S; Taenzler, J; Zschiesche, E | 1 |
Armstrong, R; Dongus, H; Meyer, L | 1 |
Beugnet, F; Fourie, J; Halos, L; Larsen, D; Lebon, W; Liebenberg, J | 1 |
Cavalleri, D; Chappell, K; Coble, S; Drake, J; Karadzovska, D; Murphy, M; Nanchen, S; Wiseman, S | 1 |
Becskei, C; Cuppens, O; Mahabir, SP | 1 |
Anukkul, P; Chen, C; Duangkaew, L; Larsuprom, L; Lekcharoensuk, C | 1 |
Otranto, D | 1 |
Ike, K; Momota, Y; Mori, A; Morita, T; Oda, H; Sako, T | 1 |
Curdi, JL; Gil, AE; Gomez, SA; Hernandez, JAC; Hernandez, PO; Peris, PP; Picado, A; Velasquez, RVO | 1 |
Charach, MG | 1 |
Ranjan, S; Sun, F; Young, D | 1 |
Cavalleri, D; Murphy, M; Nanchen, S; Seewald, W | 1 |
Abbate, JM; Arfuso, F; Beugnet, F; Brianti, E; Gaglio, G; Giannetto, S; Halos, L; Napoli, E | 1 |
Armstrong, R; Burgio, F; Lavan, R; Tunceli, K | 1 |
Baker, K; Cavalleri, D; Drake, J; Ellenberger, C; Hacket, K; Murphy, M; Nanchen, S; Seewald, W | 1 |
Heaney, K; Lavan, R; Tunceli, K; Vaduvoor, SR | 1 |
Beccati, M; Beugnet, F; Bourdeau, P; Brement, T; Bruet, V; Cekiera, A; Crosaz, O; Darmon, C; Guillot, J; Halos, L; Larsen, D; Lebon, W; Mosca, M; Pin, D; Pomorska Handwerker, D; Popiel, J; Tielemans, E | 1 |
Armstrong, R; Gopinath, D; Meyer, L; Smith, J | 1 |
Armstrong, R; Lavan, R; Normile, D; Tunceli, K | 1 |
Beugnet, F; Hampel, V; Knaus, M; Rehbein, S; Schäfer, J | 1 |
Castillo, JA; Delacour, S; Gomez, SA; Lucientes, J; Oropeza, RV; Ortega, P; Peris, MP; Picado, A | 1 |
Foppa, C; Perego, R; Proverbio, D; Spada, E | 1 |
Armstrong, R; Hirama, K; Okinaga, T; Suzuki, T; Toyota, M | 1 |
Fourie, JJ; Meyer, L; Thomas, E | 1 |
Alvedro, A; Cardinal, MV; Enriquez, GF; Gaspe, MS; Gürtler, RE; Laiño, MA | 1 |
Davitkov, D; Djuric, M; Glavinic, U; Milcic Matic, N; Stanimirovic, Z; Vejnovic, B | 1 |
Roepke, RK; Rohdich, N; Zschiesche, E | 1 |
Chester, TS; Dumont, P; Fourie, JJ; Hunter, JS; Larsen, DL; Young, DR | 1 |
Blair, J; Chester, TS; Dumont, P; Fourie, JJ; Larsen, DL | 1 |
Daly, S; Drag, M; Dumont, P; Kunkle, B; Larsen, D | 1 |
Chester, TS; Drag, M; Kinoshita, G; Kondo, Y; Larsen, D | 1 |
Benner, EA; Confalone, PN; Cordova, D; Dietrich, RF; Gould, BR; Hartline, EJ; Jones, GS; Kinney, JB; Lahm, GP; Long, JK; McDowell, RG; Rhoades, DF; Schroeder, ME; Shoop, WL; Waddell, ME; Wagerle, T; Xu, M | 1 |
Chester, TS; Dumont, P; Gale, B; Larsen, DL | 1 |
Allan, MJ; Fisara, P; Nuernberger, MC; Roepke, RK; Walther, FM | 2 |
Drag, M; Harriman, J; Huang, R; Kvaternick, V; Letendre, L; Soll, M | 1 |
Larsen, D; McCall, JW; Mitchell, EB; Theodore Chester, S | 1 |
Chester, TS; Drag, MD; Kunkle, BN; Larsen, DL | 1 |
Heckeroth, AR; Qureshi, T; Williams, H; Young, DR; Zoller, H | 1 |
Beugnet, F; Erasmus, H; Fourie, J; Halos, L; Labuschagné, M; Larsen, D | 1 |
Guerino, F; Meadows, C; Sun, F | 2 |
Beugnet, F; deVos, C; Fourie, J; Halos, L; Liebenberg, J | 1 |
Beugnet, F; Chalvet-Monfray, K; Halos, L; Larsen, D; Lebon, W | 1 |
Heckeroth, AR; Langenstein, J; Moritz, A; Roepke, RK; Wengenmayer, C; Williams, H; Zschiesche, E | 1 |
Fourie, J; Heckeroth, AR; Roepke, RK; Taenzler, J; Wengenmayer, C; Williams, H; Zschiesche, E | 1 |
Beugnet, F; Halos, L; Liebenberg, J | 1 |
Fourie, JJ; Frénais, R; Heckeroth, AR; Horak, IG; Liebenberg, JE; Taenzler, J | 1 |
Heckeroth, AR; Roepke, RK; Williams, H; Zoller, H; Zschiesche, E | 1 |
Beugnet, F | 1 |
Fisara, P; Webster, M | 1 |
Carithers, D; Chwala, M; Crevoiserat, L; Dryden, MW; Foley, KM; Hawkins, A; Jones, E; McGrady, JC; Patton, PR; Smith, V | 1 |
Heckeroth, AR; Liebenberg, J; Roepke, RK; Taenzler, J | 2 |
Demeler, J; Heckeroth, AR; Roepke, RK; Taenzler, J; Williams, H; Zschiesche, E | 1 |
Davis, WL; Everett, WR; Hostetler, J; Ohmes, CM; Settje, T | 1 |
Davis, WL; Everett, WR; Hostetler, J; McMinn, A; Ohmes, CM; Settje, T | 1 |
Bennett, T; Dryden, MW; Heaney, K; Kallman, J; Math, L; Smith, V; Sun, F | 1 |
Ackermann, AL; Frank, LA; May, ER; McEntee, MF | 1 |
Fisara, P; Shipstone, M; von Berky, A; von Berky, J | 1 |
Eguchi, N; Fukushima, K; Igarashi, H; Kanemoto, H; Nakashima, K; Ohmi, A; Ohno, K; Takahashi, M; Tsujimoto, H | 1 |
Akama, T; Balko, TW; Bu, W; Cao, J; Defauw, JM; Easom, EE; Guo, S; Plattner, JJ; White, WH; Winkle, JR; Xue, J; Zhang, YK; Zhou, Y; Zou, W | 1 |
Rumschlag, AJ; Ryan, WG; Snyder, DE; Young, LM | 1 |
Anderson, A; de Vos, C; Fourie, JJ; Jeannin, P; Larsen, DL; Rehbein, S | 1 |
Honsberger, NA; Liebenberg, J; Mahabir, SP; Six, RH | 2 |
Everett, WR; Mahabir, SP; Myers, MR; Six, RH | 1 |
Holzmer, SJ; Mahabir, SP; Six, RH; Young, DR | 1 |
Berg, TC; Heinz, TJ; Honsberger, NA; Mahabir, SP; Six, RH; Weber, A | 1 |
Becskei, C; Cuppens, O; Geurden, T; Liebenberg, J; Mahabir, SP; Six, RH | 1 |
Chubb, NA; Curtis, MP; Goodwin, RM; Hedges, L; Howson, W; Koch, JD; McTier, TL; Meeus, PF; Menon, SR; Price, JE; Pullins, A; Stuk, T; Vaillancourt, V; Woods, DJ; Zinser, EW | 1 |
Becskei, C; Cherni, JA; De Bock, F; Fourie, JJ; Illambas, J; Lane, M; Mahabir, SP; Six, RH | 1 |
Carter, L; Everett, WR; Geurden, T; Mahabir, SP; McLoughlin, A; Myers, MR; Six, RH; Slootmans, N | 1 |
Carter, L; Chapin, S; Everett, WR; Holzmer, S; Honsberger, NA; Mahabir, SP; Myers, MR; Rugg, JJ; Six, RH; Young, DR | 1 |
Colgan, S; Davis, K; Everett, WR; Geurden, T; Grace, S; Hodge, A; Mahabir, SP; Myers, MR; Packianathan, R; Six, RH; Slootmans, N | 1 |
Cherni, JA; Mahabir, SP; Six, RH | 1 |
Fourie, JJ; Hedges, L; Mahabir, SP; McTier, TL; Myers, MR; Pullins, A; Six, RH | 1 |
Becskei, C; Carter, L; Chapin, S; Gale, B; Mahabir, SP; Myers, MR; Six, RH; Young, DR | 1 |
Chubb, N; Curtis, MP; Hedges, L; Inskeep, GA; Knauer, CS; McTier, TL; Meeus, P; Menon, S; Mills, B; Pullins, A; Woods, DJ; Zinser, E | 1 |
Becskei, C; Fourie, JJ; Mahabir, SP; Mazaleski, MM; Myers, MR; Six, RH; Slootmans, N | 1 |
Becskei, C; De Bock, F; Farkas, R; Illambas, J; Mahabir, SP; Six, RH | 1 |
Chapelle, E; Cochet-Faivre, N; Crosaz, O; Guillot, J; Hubinois, C; Ka, D | 1 |
Beugnet, F; de Vos, C; Halos, L; Larsen, D | 1 |
Becskei, C; Doherty, P; Geurden, T; Grace, S; Liebenberg, J; Lloyd, A; Mahabir, SP; Six, RH; Slootmans, N; Strube, C | 1 |
Gale, B; Heckeroth, AR; Roepke, RK; Taenzler, J; Zschiesche, E | 1 |
Everett, WR; Heckeroth, AR; Liebenberg, J; Mienie, M; Roepke, RK; Sun, F; Taenzler, J; Vihtelic, TS; Young, DR; Zschiesche, E | 1 |
Allan, MJ; Kilp, S; Ramirez, D; Roepke, RK | 1 |
Crafford, D; Erasmus, H; Fourie, JJ; Jongejan, F; Schunack, B | 1 |
Beugnet, F; de Vos, C; Fourie, J; Halos, L; Larsen, D; Liebenberg, J | 1 |
Bennett, T; Canfield, MS; Crevoiserat, L; Dryden, MW; Foley, KM; Green, K; Heaney, K; Kalosy, K; Math, L; McGrady, JC; Royal, C; Smith, A; Smith, V; Sun, F; Tebaldi, C | 1 |
Bowman, DD; Crafford, D; Dorr, P; Fankhauser, R; Hamel, D; Larsen, DL; Reinemeyer, CR; Ulrich, M; Yoon, S | 1 |
Frénais, R; Heckeroth, AR; Liebenberg, J; Roepke, RK; Taenzler, J | 1 |
Cordero, AM; Heredia, R; Mendoza, GD; Pineda, J; Romero, C; Serrano, JA; Trápala, P | 1 |
Beugnet, F; Crafford, D; de Vos, C; Fourie, J; Kok, D; Larsen, D | 1 |
Beugnet, F; Dumont, P; Halos, L; Jeannin, P; Larsen, D; Lebon, W; Rehbein, S; Tielemans, E; Yoon, S | 1 |
Breiltgens, T; Brianti, E; Capári, B; Dantas-Torres, F; Dollhofer, D; Gau, M; Jeannin, P; Joachim, A; Kaulfuß, KH; Kirkova, Z; Kley, K; Knaus, M; Lebon, W; Lechner, J; Mallouk, Y; Mihalca, AD; Mirabito, R; Petkevičius, S; Rapti, D; Rehbein, S; Sedeilhan, M; Shukullari, E; Visser, M | 1 |
Drag, M; Harriman, J; Larsen, D; Letendre, L; Saik, J; Yoon, S | 1 |
Armstrong, R; Burgio, F; Meyer, L | 1 |
Carithers, D; Crawford, J; de Vos, C; Fourie, J; Lotriet, A | 1 |
de Vos, C; Frénais, R; Heckeroth, AR; Roepke, RK; Taenzler, J | 1 |
Bruellke, N; Davis, K; Hodge, A; Maeder, S; Packianathan, R | 1 |
Baker, TA; Colopy, SA; Muir, P | 1 |
Muñana, KR; Olby, NJ; Schwartz, M | 1 |
Ahn, JO; Chae, JS; Chung, JY; Hwang, CY; Kim, TH; Lee, SY; Seo, KW; Youn, HY | 1 |
Rambeck, B; Tipold, A; von Klopmann, T | 1 |
Cannon, A; DeManvelle, T; Gregory, CR; Harb, M; Morris, RE; Ortega, T; Stewart, A; Sturges, B | 1 |
2 review(s) available for isoxazoles and Canine Diseases
Article | Year |
---|---|
Arthropod-borne pathogens of dogs and cats: From pathways and times of transmission to disease control.
Topics: Animals; Arthropod Vectors; Cat Diseases; Cats; Communicable Diseases, Emerging; Disease Vectors; Dog Diseases; Dogs; Feeding Behavior; Humans; Isoxazoles; Parasitic Diseases, Animal; Pyrethrins; Zoonoses | 2018 |
Critically appraised topic for the most effective and safe treatment for canine generalised demodicosis.
Topics: Acaricides; Animals; Azetidines; Dog Diseases; Dogs; Isoxazoles; Ivermectin; Macrolides; Mite Infestations; Mites; Spiro Compounds | 2019 |
48 trial(s) available for isoxazoles and Canine Diseases
Article | Year |
---|---|
Efficacy of a single administration of afoxolaner (NexGard®) or fipronil plus permethrin (Frontline® Tri-Act) against Hyalomma marginatum ticks in dogs.
Topics: Animals; Dog Diseases; Dogs; Isoxazoles; Naphthalenes; Permethrin; Pyrazoles; Ticks | 2021 |
Control of pyrethroid-resistant populations of Triatoma infestans, the main vector of Trypanosoma cruzi, by treating dogs with fluralaner in the Argentine Chaco.
Topics: Animals; Argentina; Chagas Disease; Dog Diseases; Dogs; Insect Vectors; Insecticides; Isoxazoles; Pyrethrins; Triatoma; Trypanosoma cruzi | 2022 |
Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil.
Topics: Animals; Brazil; Dog Diseases; Dogs; Insecticides; Isoxazoles; Tunga; Tungiasis | 2022 |
Efficacy of afoxolaner (NexGard®) against natural infestations with Trichodectes canis in dogs under field conditions.
Topics: Animals; Canidae; Dog Diseases; Dogs; Ischnocera; Isoxazoles; Naphthalenes | 2022 |
Assessment of the insecticidal activity of oral afoxolaner against Phlebotomus perniciosus in dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Drug Administration Schedule; Female; Insecticides; Isoxazoles; Male; Naphthalenes; Phlebotomus; Tick Infestations | 2019 |
A single oral dose of fluralaner (Bravecto®) in dogs rapidly kills 100% of blood-fed Phlebotomus perniciosus, a main visceral leishmaniasis vector, for at least 1 month after treatment.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Female; Insect Control; Insect Vectors; Insecticides; Isoxazoles; Leishmania infantum; Leishmaniasis, Visceral; Male; Phlebotomus; Time Factors | 2020 |
Comparative efficacy of afoxolaner and ivermectin in dogs naturally infested with Rhipicephalus sanguineus sensu lato: A clinical field study conducted in Thailand.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Ivermectin; Male; Naphthalenes; Rhipicephalus sanguineus; Thailand; Tick Infestations | 2019 |
Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA.
Topics: Acaricides; Administration, Oral; Animals; Azetidines; Dermatitis; Dog Diseases; Dogs; Drug Combinations; Female; Flea Infestations; Hospitals, Animal; Isoxazoles; Macrolides; Male; Naphthalenes; Parasite Load; Pyrantel; Siphonaptera; Spiro Compounds; Tablets; Treatment Outcome; United States | 2020 |
Fluralaner (Bravecto®) induces long-term mortality of Lutzomyia longipalpis after a blood meal in treated dogs.
Topics: Animals; Brazil; Dog Diseases; Dogs; Female; Insect Vectors; Insecticides; Isoxazoles; Leishmania infantum; Leishmaniasis, Visceral; Male; Meals; Psychodidae | 2020 |
Long-term follow-up of a single dose of fluralaner in nine dogs with demodicosis.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Follow-Up Studies; Insecticides; Isoxazoles; Mite Infestations; Prospective Studies | 2021 |
Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard
Topics: Administration, Oral; Aedes; Analysis of Variance; Animals; Body Weight; Dog Diseases; Dogs; Ectoparasitic Infestations; Female; Insect Vectors; Insecticides; Isoxazoles; Male; Naphthalenes | 2017 |
A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Flea Infestations; Hospitals, Animal; Insecticides; Isoxazoles; Naphthalenes; Siphonaptera; Tablets; United States | 2017 |
Efficacy and safety of sarolaner in the treatment of canine ear mite infestation caused by Otodectes cynotis: a non-inferiority study.
Topics: Administration, Oral; Administration, Topical; Animals; Azetidines; Dog Diseases; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Insecticides; Isoxazoles; Macrolides; Male; Mite Infestations; Pets; Psoroptidae; Spiro Compounds | 2018 |
Phlebotomine mortality effect of systemic insecticides administered to dogs.
Topics: Absorption, Physiological; Animals; Disease Vectors; Dog Diseases; Dogs; Drug Combinations; Female; Insecticides; Isoxazoles; Leishmania infantum; Leishmaniasis, Visceral; Macrolides; Male; Naphthalenes; Phlebotomus | 2018 |
Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio™) against Ctenocephalides felis on cats.
Topics: Administration, Oral; Animals; Cats; Ctenocephalides; Dog Diseases; Dogs; Flea Infestations; Insecticides; Isoxazoles; Safety; Tablets; Treatment Outcome | 2018 |
Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra®.
Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Female; Insect Vectors; Insecticides; Isoxazoles; Macrolides; Male; Naphthalenes; Parasitic Diseases, Animal; Permethrin; Pyrazoles | 2018 |
Topical or oral fluralaner efficacy against flea (Ctenocephalides felis) transmission of Dipylidium caninum infection to dogs.
Topics: Administration, Oral; Administration, Topical; Animals; Anticestodal Agents; Cestode Infections; Ctenocephalides; Dog Diseases; Dogs; Female; Insect Vectors; Isoxazoles; Male; Single-Blind Method | 2018 |
Treatment of canine sarcoptic mange with afoxolaner (NexGard
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Germany; Isoxazoles; Macrolides; Male; Naphthalenes; Portugal; Random Allocation; Scabies; Tablets; Treatment Outcome | 2018 |
A randomized, blinded, controlled trial to assess sand fly mortality of fluralaner administered orally in dogs.
Topics: Animals; Dog Diseases; Dogs; Female; Insect Vectors; Insecticides; Isoxazoles; Leishmaniasis, Visceral; Male; Phlebotomus; Psychodidae; Random Allocation; Treatment Outcome | 2018 |
An oral dose of Fluralaner administered to dogs kills pyrethroid-resistant and susceptible Chagas disease vectors for at least four months.
Topics: Administration, Oral; Animals; Chagas Disease; Dog Diseases; Dogs; Drug Resistance; Insect Vectors; Insecticides; Isoxazoles; Nymph; Pyrethrins; Random Allocation; Treatment Outcome; Triatoma | 2019 |
A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs.
Topics: Acaricides; Administration, Oral; Administration, Topical; Animals; Dog Diseases; Dogs; Female; Flea Infestations; France; Germany; Insecticides; Isoxazoles; Male; Pyrazoles; Single-Blind Method; Siphonaptera; Spain; Tablets; Tick Infestations; Ticks; Treatment Outcome | 2014 |
Fluralaner, a novel isoxazoline, prevents flea (Ctenocephalides felis) reproduction in vitro and in a simulated home environment.
Topics: Animals; Ctenocephalides; Dog Diseases; Dogs; Female; Flea Infestations; Housing; Insecticides; Isoxazoles; Larva; Ovum; Reproduction | 2014 |
The ability of an oral formulation of afoxolaner to block the transmission of Babesia canis by Dermacentor reticulatus ticks to dogs.
Topics: Acaricides; Administration, Oral; Animals; Babesia; Dermacentor; Dog Diseases; Dogs; Female; Isoxazoles; Male; Naphthalenes; Tick Infestations | 2014 |
A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations.
Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Female; Flea Infestations; Insecticides; Isoxazoles; Macrolides; Male; Tablets; Toluidines; United States | 2014 |
Afoxolaner against fleas: immediate efficacy and resultant mortality after short exposure on dogs.
Topics: Animals; Ctenocephalides; Dog Diseases; Dogs; Excitatory Amino Acid Antagonists; Flea Infestations; GABA Antagonists; Insect Proteins; Insecticides; Isoxazoles; Naphthalenes; Time Factors; Treatment Outcome | 2014 |
Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime-praziquantel.
Topics: Animals; Anthelmintics; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Insecticides; Isoxazoles; Macrolides; Male; Praziquantel | 2014 |
The speed of kill of fluralaner (Bravecto™) against Ixodes ricinus ticks on dogs.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Ixodes; Male; Tick Infestations; Time Factors | 2014 |
Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Female; Flea Infestations; Insecticides; Isoxazoles; Male | 2014 |
Comparative speed of efficacy against Ctenocephalides felis of two oral treatments for dogs containing either afoxolaner or fluralaner.
Topics: Administration, Oral; Animals; Ctenocephalides; Dog Diseases; Dogs; Flea Infestations; Insecticides; Isoxazoles; Naphthalenes; Time Factors; Treatment Outcome | 2015 |
Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Female; Imidazoles; Insecticides; Isoxazoles; Macrolides; Male; Mite Infestations; Neonicotinoids; Nitro Compounds | 2015 |
A randomized controlled trial of the efficacy of orally administered fluralaner (Bravecto™) against induced Ixodes holocyclus (Australian paralysis tick) infestations on dogs.
Topics: Acaricides; Administration, Oral; Animals; Australia; Dog Diseases; Dogs; Female; Isoxazoles; Ixodes; Male; Tick Control; Tick Infestations | 2015 |
Comparative Efficacy of an Imidacloprid/Flumethrin Collar (Seresto®) and an Oral Afoxolaner Chewable (NexGard®) against Tick (Dermacentor variabilis and Amblyomma americanum) Infestations on Dogs: a Randomised Controlled Trial.
Topics: Administration, Oral; Administration, Topical; Animals; Dog Diseases; Dogs; Imidazoles; Insecticides; Isoxazoles; Ixodidae; Naphthalenes; Neonicotinoids; Nitro Compounds; Pyrethrins; Tick Infestations | 2015 |
Speed of flea knockdown of spinosad compared to afoxolaner, and of spinosad through 28 days post-treatment in controlled laboratory studies.
Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Flea Infestations; Insecticides; Isoxazoles; Macrolides; Naphthalenes; Siphonaptera; Time Factors; United States | 2015 |
Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced infestations with Dermacentor reticulatus in dogs.
Topics: Acaricides; Administration, Oral; Animals; Dermacentor; Dog Diseases; Dogs; Drug Combinations; Isoxazoles; Macrolides; Naphthalenes; Tick Infestations; Treatment Outcome | 2016 |
Efficacy of sarolaner in the prevention of Borrelia burgdorferi and Anaplasma phagocytophilum transmission from infected Ixodes scapularis to dogs.
Topics: Acaricides; Anaplasma phagocytophilum; Animals; Antibodies, Bacterial; Arachnid Vectors; Borrelia burgdorferi; Disease Transmission, Infectious; Dog Diseases; Dogs; Ehrlichiosis; Female; Isoxazoles; Ixodes; Lyme Disease; Male; Tick Infestations; Treatment Outcome | 2016 |
Efficacy and safety of sarolaner (Simparica™) against fleas on dogs presented as veterinary patients in the United States.
Topics: Animals; Dog Diseases; Dogs; Female; Flea Infestations; Insecticides; Isoxazoles; Male; Treatment Outcome; United States | 2016 |
Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Europe; Flea Infestations; Insecticides; Isoxazoles; Siphonaptera; Tick Infestations; Ticks; Treatment Outcome | 2016 |
Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Female; Follow-Up Studies; Imidazoles; Isoxazoles; Macrolides; Male; Mite Infestations; Naphthalenes; Neonicotinoids; Nitro Compounds; Skin; Tablets; Time Factors | 2016 |
Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix(®)) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs.
Topics: Acaricides; Administration, Oral; Administration, Topical; Animals; Arachnid Vectors; Dog Diseases; Dogs; Drug Combinations; Drug Therapy, Combination; Ehrlichia canis; Ehrlichiosis; Imidazoles; Insecticides; Isoxazoles; Naphthalenes; Neonicotinoids; Nitro Compounds; Permethrin; Rhipicephalus sanguineus; Tick Infestations | 2016 |
Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Male; Naphthalenes; Sarcoptes scabiei; Scabies; Skin | 2016 |
Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs.
Topics: Animals; Azetidines; Dog Diseases; Dogs; Insecticides; Isoxazoles; Ixodidae; Placebos; Spiro Compounds; Tick Infestations; Treatment Outcome | 2016 |
Efficacy of fluralaner in 17 dogs with sarcoptic mange.
Topics: Animals; Dog Diseases; Dogs; Female; Insecticides; Isoxazoles; Male; Scabies | 2016 |
Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra(®), Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs.
Topics: Administration, Oral; Analysis of Variance; Animals; Anthelmintics; Aorta, Thoracic; Autopsy; Body Weight; Dog Diseases; Dogs; Esophagoscopy; Esophagus; Feces; Female; Isoxazoles; Macrolides; Male; Naphthalenes; Parasite Egg Count; Spirurida Infections; Thelazioidea | 2016 |
Monthly administrations of milbemycin oxime plus afoxolaner chewable tablets to prevent Angiostrongylus vasorum infection in dogs.
Topics: Angiostrongylus; Animals; Anthelmintics; Dog Diseases; Dogs; Drug Administration Schedule; Drug Synergism; Female; Isoxazoles; Macrolides; Male; Naphthalenes; Strongylida Infections; Tablets | 2016 |
Safety evaluation of orally administered afoxolaner and milbemycin oxime in eight-week-old dogs.
Topics: Administration, Oral; Animals; Antiparasitic Agents; Dog Diseases; Dogs; Female; Isoxazoles; Macrolides; Male; Naphthalenes | 2017 |
A randomized, blinded, controlled USA field study to assess the use of fluralaner topical solution in controlling canine flea infestations.
Topics: Administration, Topical; Animals; Dog Diseases; Dogs; Flea Infestations; Insecticides; Isoxazoles; Parasite Load; Single-Blind Method; Solutions; Treatment Outcome; United States | 2017 |
Zonisamide monotherapy for idiopathic epilepsy in dogs.
Topics: Animals; Anticonvulsants; Dog Diseases; Dogs; Epilepsy; Isoxazoles; Zonisamide | 2012 |
Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogs.
Topics: Administration, Oral; Animals; Anticonvulsants; Dog Diseases; Dogs; Epilepsy; Isoxazoles; Prospective Studies; Treatment Outcome; Zonisamide | 2007 |
87 other study(ies) available for isoxazoles and Canine Diseases
Article | Year |
---|---|
Insecticidal efficacy of fluralaner (Bravecto
Topics: Animals; Brazil; Chagas Disease; Dog Diseases; Dogs; Female; Insect Vectors; Insecticides; Isoxazoles; Male; Nymph; Random Allocation; Triatoma | 2021 |
Efficacy of afoxolaner for the treatment of ear mite infestation under field conditions.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Isoxazoles; Mite Infestations; Mites; Naphthalenes; Treatment Outcome | 2021 |
Evaluation of the effectiveness of fluralaner against adult stages of Rhodnius prolixus in dogs.
Topics: Animals; Chagas Disease; Dog Diseases; Dogs; Female; Insect Vectors; Isoxazoles; Male; Rhodnius; Trypanosoma cruzi | 2022 |
Insecticidal efficacy against Phlebotomus perniciosus in dogs treated orally with fluralaner in two different parallel-group, negative-control, random and masked trials.
Topics: Administration, Oral; Animals; Disease Reservoirs; Dog Diseases; Dogs; Female; Insect Vectors; Insecticides; Isoxazoles; Leishmania infantum; Leishmaniasis, Visceral; Phlebotomus; Random Allocation; Specific Pathogen-Free Organisms | 2022 |
Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1-deficient collie dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Isoxazoles; Macrolides; Naphthalenes | 2022 |
Afoxolaner (NexGard®) in pet snakes for the treatment and control of Ophionyssus natricis (Mesostigmata: Macronyssidae).
Topics: Animals; Dog Diseases; Dogs; Isoxazoles; Mite Infestations; Mites; Snakes | 2023 |
Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog.
Topics: Animals; Central Nervous System Diseases; Dog Diseases; Dogs; Female; Insecticides; Isoxazoles | 2019 |
Survey of canine use and safety of isoxazoline parasiticides.
Topics: Animals; Antiparasitic Agents; Azetidines; Dog Diseases; Dogs; Flea Infestations; Isoxazoles; Naphthalenes; Spiro Compounds; Tick Infestations | 2020 |
A European field assessment of the efficacy of fluralaner (Bravecto
Topics: Acaricides; Administration, Oral; Administration, Topical; Animals; Dog Diseases; Dogs; Europe; Isoxazoles; Macrolides; Mastication; Mite Infestations; Mites; Skin; Treatment Outcome | 2020 |
Evaluation of oral fluralaner (Bravecto
Topics: Acaricides; Administration, Oral; Amblyomma; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Male; Nymph; Parasite Load; Rhipicephalus sanguineus; Tick Infestations; Treatment Outcome | 2020 |
Flea and tick treatment satisfaction, preference, and adherence of dog owners in the United States, United Kingdom, and Australia who treated their dog with fluralaner.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Australia; Child; Dog Diseases; Dogs; Female; Flea Infestations; Humans; Isoxazoles; Male; Middle Aged; Personal Satisfaction; Tick Infestations; United Kingdom; United States; Young Adult | 2020 |
Efficacy of afoxolaner (NexGard®) on the treatment of myiasis caused by the New World screwworm fly Cochliomyia hominivorax (Diptera: Calliphoridae) in naturally infested dogs.
Topics: Animals; Calliphoridae; Diptera; Dog Diseases; Dogs; Isoxazoles; Myiasis; Naphthalenes | 2021 |
Efficacy of afoxolaner (NexGard®) in preventing the transmission of Leishmania infantum and Dirofilaria immitis to sheltered dogs in a highly endemic area.
Topics: Animals; Dirofilaria immitis; Dirofilariasis; Dog Diseases; Dogs; Endemic Diseases; Female; Insect Vectors; Isoxazoles; Leishmania infantum; Leishmaniasis, Visceral; Mosquito Vectors; Naphthalenes; Psychodidae; Weather | 2021 |
The conclusion of a comparative efficacy study of fluralaner and sarolaner against the tick Amblyomma americanum on dogs is based on results obtained at study times that are outside the fluralaner label recommendations.
Topics: Animals; Azetidines; Dog Diseases; Dogs; Insecticides; Isoxazoles; Ixodidae; Spiro Compounds; Tick Infestations; Treatment Outcome; United States | 2017 |
Efficacy of afoxolaner plus milbemycin oxime chewable tablets (NexGard Spectra
Topics: Ancylostoma; Ancylostomiasis; Animals; Anthelmintics; Dog Diseases; Dogs; Drug Combinations; Female; Isoxazoles; Macrolides; Male; Naphthalenes; Tablets | 2017 |
Response to the Letter to the Editor by Rob Armstrong.
Topics: Animals; Clinical Studies as Topic; Dog Diseases; Dogs; Insecticides; Isoxazoles; Ixodidae; Research Design; Tick Infestations; Treatment Outcome | 2017 |
Afoxolaner and fluralaner treatment do not impact on cutaneous Demodex populations of healthy dogs.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Male; Mite Infestations; Mites; Naphthalenes; Treatment Outcome | 2017 |
A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs.
Topics: Animals; Dog Diseases; Dogs; Female; Immune System Diseases; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Retrospective Studies | 2017 |
Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs.
Topics: Administration, Oral; Administration, Topical; Animals; Anoplura; Dog Diseases; Dogs; Female; Insecticides; Isoxazoles; Lice Infestations; Male; Permethrin; Random Allocation; Tablets; Treatment Outcome | 2017 |
Water immersion of dogs close to the time of topical fluralaner treatment does not reduce efficacy against a subsequent experimental challenge with Rhipicephalus sanguineus (sensu lato).
Topics: Acaricides; Administration, Topical; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Male; Rhipicephalus sanguineus; Tick Infestations; Veterinary Medicine; Water | 2017 |
A field trial in Thailand of the efficacy of oral fluralaner for the treatment of dogs with generalized demodicosis.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Isoxazoles; Mite Infestations; Mites; Thailand | 2018 |
Successful treatment of refractory demodicosis and transient papules with a single dose of fluralaner in a dog with uncontrolled severe endocrine disease.
Topics: Acaricides; Adrenocortical Hyperfunction; Animals; Dog Diseases; Dogs; Female; Hypothyroidism; Isoxazoles; Mite Infestations | 2018 |
Demodicosis: New treatment, common misdiagnosis.
Topics: Animals; Dog Diseases; Dogs; Insecticides; Isoxazoles; Mite Infestations; Mites | 2018 |
A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment.
Topics: Administration, Topical; Animals; Cat Diseases; Cats; Ctenocephalides; Dog Diseases; Dogs; Female; Flea Infestations; Housing; Isoxazoles; Male; Siphonaptera; Time Factors; Treatment Outcome | 2018 |
Duration of annual canine flea and tick protection provided by dog owners in Spain.
Topics: Administration, Oral; Administration, Topical; Animals; Delayed-Action Preparations; Dog Diseases; Dogs; Drug Administration Schedule; Flea Infestations; Humans; Insecticides; Isoxazoles; Ownership; Retrospective Studies; Seasons; Spain; Tick Infestations | 2018 |
Laboratory evaluations of the 3-month efficacy of oral lotilaner (Credelio™) against experimental infestations of dogs with the Australian paralysis tick, Ixodes holocyclus.
Topics: Administration, Oral; Animals; Australia; Dog Diseases; Dogs; Female; Insecticides; Isoxazoles; Ixodes; Laboratories; Male; Neurotoxins; Tablets; Tick Infestations; Tick Paralysis; Time Factors | 2018 |
A comparative analysis of heartworm medication use patterns for dogs that also receive ectoparasiticides.
Topics: Acaricides; Animals; Antiparasitic Agents; Dirofilaria immitis; Dirofilariasis; Dog Diseases; Dogs; Drug Utilization; Flea Infestations; Humans; Isoxazoles; Ownership; Pets; Tick Infestations; Treatment Outcome | 2018 |
Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe.
Topics: Acaricides; Administration, Oral; Animals; Anthelmintics; Dog Diseases; Dogs; Drug Compounding; Female; Isoxazoles; Macrolides; Male; Mite Infestations; Mites; Naphthalenes; Skin; Treatment Outcome | 2018 |
Dog owner flea/tick medication purchases in the USA.
Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Flea Infestations; Hospitals, Animal; Humans; Insecticides; Isoxazoles; Macrolides; Medication Adherence; Naphthalenes; Ownership; Prescription Drugs; Records; Siphonaptera; Ticks; United States; Veterinary Drugs; Veterinary Medicine | 2018 |
Efficacy of orally administered fluralaner in dogs against laboratory challenge with Haemaphysalis longicornis ticks.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Ixodidae; Laboratories; Male; Tick Control; Tick Infestations | 2019 |
Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis.
Topics: Administration, Topical; Animals; Dog Diseases; Dogs; Insecticides; Isoxazoles; Macrolides; Mite Infestations; Mites; Neonicotinoids; Nitro Compounds; Random Allocation; Treatment Outcome | 2019 |
Efficacy of oral fluralaner for the treatment of canine generalized demodicosis: a molecular-level confirmation.
Topics: Acaricides; Administration, Oral; Animals; Arthropod Proteins; Dog Diseases; Dogs; Female; Isoxazoles; Male; Mite Infestations; Mites; Real-Time Polymerase Chain Reaction; Skin; Treatment Outcome | 2019 |
Evaluation of the curative and preventive efficacy of a single oral administration of afoxolaner against cat flea Ctenocephalides felis infestations on dogs.
Topics: Administration, Oral; Animals; Antiparasitic Agents; Ctenocephalides; Dog Diseases; Dogs; Female; Flea Infestations; Isoxazoles; Male; Naphthalenes; Parasite Egg Count; Random Allocation; Treatment Outcome | 2014 |
Evaluation of the efficacy of afoxolaner against two European dog tick species: Dermacentor reticulatus and Ixodes ricinus.
Topics: Acaricides; Animals; Dermacentor; Dog Diseases; Dogs; Female; Isoxazoles; Ixodes; Male; Naphthalenes; Parasite Load; Random Allocation; Tick Infestations; Treatment Outcome | 2014 |
Assessment of the efficacy of orally administered afoxolaner against Rhipicephalus sanguineus sensu lato.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Male; Naphthalenes; Random Allocation; Rhipicephalus sanguineus; Tick Infestations; Treatment Outcome | 2014 |
Evaluation of the efficacy of afoxolaner against Haemaphysalis longicornis on dogs.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Ixodidae; Male; Naphthalenes; Random Allocation; Tick Infestations; Treatment Outcome | 2014 |
Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs.
Topics: Animals; Antiparasitic Agents; Chloride Channels; Cockroaches; Dog Diseases; Dogs; Drosophila melanogaster; Electrophysiological Phenomena; Female; Flea Infestations; Isoxazoles; Male; Naphthalenes; Oocytes; Protein Binding; Random Allocation; Siphonaptera; Tick Infestations; Ticks; Xenopus laevis | 2014 |
Curative and preventive efficacy of orally administered afoxolaner against Ctenocephalides canis infestation in dogs.
Topics: Administration, Oral; Animals; Ctenocephalides; Dog Diseases; Dogs; Female; Flea Infestations; Isoxazoles; Male; Naphthalenes; Parasite Egg Count; Parasite Load; Treatment Outcome | 2014 |
Safety of the concurrent treatment of dogs with Bravecto (fluralaner) and Scalibor protectorband (deltamethrin).
Topics: Animals; Dog Diseases; Dogs; Drug Interactions; Insect Control; Insecticides; Isoxazoles; Nitriles; Pyrethrins; Tick Control; Tick Infestations | 2014 |
The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs.
Topics: Administration, Intravenous; Administration, Oral; Animals; Antiparasitic Agents; Area Under Curve; Dog Diseases; Dogs; Female; Flea Infestations; Isoxazoles; Male; Naphthalenes; Protein Binding; Tick Infestations | 2014 |
Efficacy of afoxolaner against Ixodes scapularis ticks in dogs.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Ixodes; Male; Naphthalenes; Parasite Load; Random Allocation; Tick Infestations; Treatment Outcome | 2014 |
Assessment of the onset of action of afoxolaner against existing adult flea (Ctenocephalides felis) infestations on dogs.
Topics: Administration, Oral; Animals; Antiparasitic Agents; Ctenocephalides; Dog Diseases; Dogs; Female; Flea Infestations; Isoxazoles; Male; Naphthalenes; Random Allocation; Time | 2014 |
Immediate efficacy and persistent speed of kill of a novel oral formulation of afoxolaner (NexGardTM) against induced infestations with Ixodes ricinus ticks.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Ixodes; Male; Naphthalenes; Random Allocation; Tick Infestations; Time Factors | 2014 |
Fluralaner activity against life stages of ticks using Rhipicephalus sanguineus and Ornithodoros moubata IN in vitro contact and feeding assays.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Feeding Behavior; Female; Isoxazoles; Male; Ornithodoros; Rhipicephalus sanguineus; Tick Infestations | 2015 |
Letter to the editor.
Topics: Animals; Ctenocephalides; Dog Diseases; Flea Infestations; Isoxazoles; Naphthalenes | 2015 |
Reply to letter to the editor.
Topics: Animals; Ctenocephalides; Dog Diseases; Flea Infestations; Isoxazoles; Naphthalenes | 2015 |
Evaluation of afoxolaner chewables to control flea populations in naturally infested dogs in private residences in Tampa FL, USA.
Topics: Administration, Oral; Animals; Animals, Domestic; Dog Diseases; Dogs; Drug Evaluation; Female; Flea Infestations; Insecticides; Isoxazoles; Male; Naphthalenes; Pest Control; Pets; Siphonaptera | 2015 |
Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™).
Topics: Administration, Oral; Animals; Arachnid Vectors; Babesia; Babesiosis; Dermacentor; Dog Diseases; Dogs; Female; Isoxazoles; Male; Tablets; Tick Infestations | 2015 |
A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto) treated vs. untreated dogs using the parameters tick weight and coxal index.
Topics: Acaricides; Animals; Body Weight; Dog Diseases; Dogs; Drug Evaluation; Female; Isoxazoles; Ixodes; Male; Tick Infestations | 2015 |
Comparative Efficacy of an Imidacloprid/Flumethrin Collar (Seresto®) and an Oral Fluralaner Chewable Tablet (Bravecto®) against Tick (Dermacentor variabilis and Amblyomma americanum) Infestations on Dogs: a Randomised Controlled Trial.
Topics: Administration, Oral; Administration, Topical; Animals; Dog Diseases; Dogs; Imidazoles; Isoxazoles; Ixodidae; Male; Neonicotinoids; Nitro Compounds; Pyrethrins; Tick Infestations | 2015 |
Efficacy of fluralaner flavored chews (Bravecto) administered to dogs against the adult cat flea, Ctenocephalides felis felis and egg production.
Topics: Administration, Oral; Animals; Cat Diseases; Cats; Ctenocephalides; Dog Diseases; Dogs; Drug Evaluation; Female; Flea Infestations; Isoxazoles; Male; Parasite Egg Count | 2015 |
Erythema multiforme associated with zonisamide in a dog.
Topics: Animals; Anticonvulsants; Dog Diseases; Dogs; Epilepsy; Erythema Multiforme; Isoxazoles; Male; Skin; Zonisamide | 2015 |
A small-scale open-label study of the treatment of canine flea allergy dermatitis with fluralaner.
Topics: Administration, Oral; Animals; Dermatitis, Allergic Contact; Dog Diseases; Dogs; Female; Flea Infestations; Insecticides; Isoxazoles; Male | 2015 |
Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds.
Topics: Animals; Colonic Polyps; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Intestinal Polyps; Isoxazoles; Leflunomide; Male; Retrospective Studies | 2016 |
Discovery of an orally bioavailable isoxazoline benzoxaborole (AN8030) as a long acting animal ectoparasiticide.
Topics: Administration, Oral; Animals; Boron Compounds; Dog Diseases; Dogs; Drug Discovery; Ectoparasitic Infestations; Isoxazoles; Molecular Structure; Structure-Activity Relationship; Time Factors | 2015 |
Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard against induced infestations of Ixodes scapularis on dogs.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Isoxazoles; Ixodes; Parasite Load; Placebos; Survival Analysis; Tick Infestations; Time Factors; Treatment Outcome | 2016 |
Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Ctenocephalides felis on dogs.
Topics: Administration, Oral; Animals; Ctenocephalides; Dog Diseases; Dogs; Flea Infestations; Insecticides; Isoxazoles; Parasite Load; Placebos; Survival Analysis; Time Factors; Treatment Outcome | 2016 |
Comparative speed of kill of sarolaner (Simparica and fluralaner (Bravecto) against induced infestations of Ctenocephalides felis on dogs.
Topics: Administration, Oral; Animals; Ctenocephalides; Dog Diseases; Dogs; Flea Infestations; Insecticides; Isoxazoles; Parasite Load; Placebos; Survival Analysis; Time Factors; Treatment Outcome | 2016 |
Comparative speed of kill of sarolaner (Simparica) and spinosad plus milbemycin oxime (Trifexis) against induced infestations of Ctenocephalides felis on dogs.
Topics: Administration, Oral; Animals; Ctenocephalides; Dog Diseases; Dogs; Drug Combinations; Flea Infestations; Insecticides; Isoxazoles; Macrolides; Parasite Load; Placebos; Survival Analysis; Time Factors; Treatment Outcome | 2016 |
Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Rhipicephalus sanguineus s.l. on dogs.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Isoxazoles; Parasite Load; Placebos; Rhipicephalus sanguineus; Survival Analysis; Tick Infestations; Time Factors; Treatment Outcome | 2016 |
Comparative speed of kill of oral treatments with Simparica™ (sarolaner) and Bravecto®(fluralaner) against induced infestations of Rhipicephalus sanguineus on dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Insecticides; Isoxazoles; Ixodes; Naphthalenes; Placebos; Random Allocation; Survival Analysis; Tick Infestations; Time Factors; Treatment Outcome | 2016 |
Design and synthesis of sarolaner, a novel, once-a-month, oral isoxazoline for the control of fleas and ticks on dogs.
Topics: Animals; Antiparasitic Agents; Ctenocephalides; Dog Diseases; Dogs; Female; Flea Infestations; Isoxazoles; Male; Rhipicephalus sanguineus; Siphonaptera; Tick Infestations; Ticks | 2016 |
Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs.
Topics: Administration, Oral; Administration, Topical; Animals; Dog Diseases; Dogs; Female; Insecticides; Isoxazoles; Male; Parasite Load; Scabies; Treatment Outcome | 2016 |
Evaluation of the speed of kill of sarolaner (Simparica™) against induced infestations of three species of ticks (Amblyomma maculatum, Ixodes scapularis, Ixodes ricinus) on dogs.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Male; Tick Infestations; Ticks; Time Factors; Treatment Outcome | 2016 |
Efficacy of a novel oral formulation of sarolaner (Simparica™) against five common tick species infesting dogs in the United States.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Isoxazoles; Random Allocation; Tick Infestations; Ticks; Treatment Outcome; United States | 2016 |
Evaluation of the effectiveness of a novel oral formulation of sarolaner (Simparica™) for the treatment and control of fleas on dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Drug Compounding; Female; Flea Infestations; Insecticides; Isoxazoles; Male; Treatment Outcome | 2016 |
Determination of the effective dose of a novel oral formulation of sarolaner (Simparica™) for the treatment and month-long control of fleas and ticks on dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Ectoparasitic Infestations; Insecticides; Isoxazoles; Siphonaptera; Ticks; Treatment Outcome | 2016 |
Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica™) against fleas on dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Flea Infestations; Insecticides; Isoxazoles; Reproduction; Siphonaptera; Treatment Outcome | 2016 |
Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Ectoparasitic Infestations; Half-Life; Insecticides; Isoxazoles; Siphonaptera; Ticks | 2016 |
Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis.
Topics: Animals; Dog Diseases; Dogs; Female; Insecticides; Isoxazoles; Male; Mite Infestations; Mites; Random Allocation; Treatment Outcome | 2016 |
Open field study on the efficacy of oral fluralaner for long-term control of flea allergy dermatitis in client-owned dogs in Ile-de-France region.
Topics: Animals; Dermatitis, Allergic Contact; Dog Diseases; Dogs; Flea Infestations; France; Insecticides; Isoxazoles; Treatment Outcome | 2016 |
Efficacy of a novel oral formulation of sarolaner (Simparica™) against four common tick species infesting dogs in Europe.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Drug Compounding; Europe; Isoxazoles; Random Allocation; Tick Infestations; Ticks; Treatment Outcome | 2016 |
The effect of water and shampooing on the efficacy of fluralaner spot-on solution against Ixodes ricinus and Ctenocephalides felis infestations in dogs.
Topics: Acaricides; Administration, Topical; Animals; Baths; Ctenocephalides; Dog Diseases; Dogs; Female; Flea Infestations; Insecticides; Isoxazoles; Ixodes; Male; Pharmaceutical Solutions; Skin Absorption; Soaps; Tick Infestations; Treatment Outcome; Water | 2016 |
Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs after topical administration of fluralaner spot-on solution.
Topics: Acaricides; Administration, Topical; Animals; Arachnid Vectors; Babesia; Babesiosis; Dermacentor; Dog Diseases; Dogs; Female; Isoxazoles; Male; Pharmaceutical Solutions; Tick Infestations; Treatment Outcome | 2016 |
Efficacy of fluralaner spot-on solution against induced infestations with Rhipicephalus sanguineus on dogs.
Topics: Acaricides; Administration, Topical; Animals; Arachnid Vectors; Dog Diseases; Dogs; Female; Isoxazoles; Male; Pharmaceutical Solutions; Rhipicephalus sanguineus; Tick Infestations; Treatment Outcome | 2016 |
Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration.
Topics: Acaricides; Administration, Intravenous; Administration, Topical; Animals; Arachnid Vectors; Cat Diseases; Cats; Dog Diseases; Dogs; Female; Flea Infestations; Insect Vectors; Insecticides; Isoxazoles; Male; Pharmaceutical Solutions; Siphonaptera; Tick Infestations; Ticks; Treatment Outcome | 2016 |
Evaluation of fluralaner and afoxolaner treatments to control flea populations, reduce pruritus and minimize dermatologic lesions in naturally infested dogs in private residences in west central Florida USA.
Topics: Animals; Dog Diseases; Dogs; Flea Infestations; Florida; Insecticides; Isoxazoles; Naphthalenes; Pruritus; Siphonaptera | 2016 |
Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced gastrointestinal nematode infections in dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Drug Combinations; Isoxazoles; Macrolides; Naphthalenes; Nematode Infections; Random Allocation; Treatment Outcome | 2016 |
Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
Topics: Acaricides; Administration, Oral; Administration, Topical; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Male; Sarcoptes scabiei; Scabies; Tablets | 2016 |
Efficacy against nematode infections and safety of afoxolaner plus milbemycin oxime chewable tablets in domestic dogs under field conditions in Europe.
Topics: Animals; Antinematodal Agents; Dog Diseases; Dogs; Europe; Feces; Isoxazoles; Macrolides; Naphthalenes; Nematoda; Nematode Infections; Praziquantel; Tablets; Treatment Outcome | 2017 |
A comparative laboratory trial evaluating the immediate efficacy of fluralaner, afoxolaner, sarolaner and imidacloprid + permethrin against adult Rhipicephalus sanguineus (sensu lato) ticks attached to dogs.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Female; Imidazoles; Isoxazoles; Male; Naphthalenes; Neonicotinoids; Nitro Compounds; Parasite Load; Permethrin; Random Allocation; Rhipicephalus sanguineus; Tick Infestations; Treatment Outcome | 2016 |
Assessment of afoxolaner efficacy against Otodectes cynotis infestations of dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Drug-Related Side Effects and Adverse Reactions; Insecticides; Isoxazoles; Mite Infestations; Naphthalenes; Otoscopy; Psoroptidae; Treatment Outcome | 2016 |
Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats.
Topics: Acaricides; Administration, Topical; Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Female; Isoxazoles; Male; Mite Infestations; Psoroptidae | 2017 |
Comparative speed of kill of sarolaner (Simparica
Topics: Animals; Australia; Azetidines; Dog Diseases; Dogs; Isoxazoles; Ixodes; Naphthalenes; Parasite Load; Placebos; Random Allocation; Spiro Compounds; Survival Analysis; Tick Infestations; Time Factors | 2017 |
Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Autoimmune Diseases; Dog Diseases; Dogs; Female; Isoxazoles; Leflunomide; Male; Retrospective Studies | 2010 |
Possible drug-induced hepatopathy in a dog receiving zonisamide monotherapy for treatment of cryptogenic epilepsy.
Topics: Animals; Anticonvulsants; Chemical and Drug Induced Liver Injury; Dog Diseases; Dogs; Epilepsy; Female; Isoxazoles; Zonisamide | 2011 |
Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy.
Topics: Aniline Compounds; Animals; Crotonates; Dog Diseases; Dogs; Female; Hydroxybutyrates; Immune System Diseases; Immunosuppressive Agents; Inflammation; Isoxazoles; Leflunomide; Male; Nitriles; Syndrome; Toluidines | 1998 |